Richard Eastell
#47,312
Most Influential Person Now
British medical academic
Richard Eastell's AcademicInfluence.com Rankings
Richard Eastellphilosophy Degrees
Philosophy
#3104
World Rank
#5091
Historical Rank
Logic
#1040
World Rank
#1661
Historical Rank
Download Badge
Philosophy
Why Is Richard Eastell Influential?
(Suggest an Edit or Addition)According to Wikipedia, Richard Eastell MD, FRCP , FRCPath, FMedSci is a British medical doctor and Professor of Bone Metabolism at the University of Sheffield. He was born in Shipley and attended the Salt Grammar School, later graduating from the University of Edinburgh in 1977 with an MB ChB and in 1984 with an MD and achieved prominence as an expert in osteoporosis.
Richard Eastell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (2009) (2299)
- Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2007) (2189)
- Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis (2000) (1601)
- Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. (2001) (1551)
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture (2012) (1045)
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus (2015) (959)
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards (2011) (915)
- Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. (2014) (863)
- Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial (2009) (737)
- Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. (2000) (713)
- The Use of Biochemical Markers of Bone Turnover in Osteoporosis (2000) (688)
- Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS) (2002) (645)
- Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial (1997) (643)
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate (2003) (596)
- The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) (588)
- Classification of vertebral fractures (1991) (587)
- Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. (2002) (543)
- Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study (2004) (487)
- Osteoporosis in men: an Endocrine Society clinical practice guideline. (2012) (448)
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. (2009) (436)
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension (2018) (434)
- Treatment of postmenopausal osteoporosis. (1998) (419)
- Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. (2010) (392)
- The effects of tibolone in older postmenopausal women. (2008) (386)
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. (2019) (382)
- Intrauterine programming of adult body composition. (2001) (377)
- Prevalence and incidence of vertebral deformities (1993) (375)
- Cancellous bone remodeling in type i (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels (1990) (366)
- Growth in infancy and bone mass in later life (1995) (358)
- Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. (2017) (344)
- Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. (2008) (343)
- Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus (2016) (337)
- A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update (1998) (337)
- The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. (2004) (332)
- Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis (1991) (299)
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis (2012) (295)
- Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2‐Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230) (2006) (290)
- Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. (1995) (288)
- Postmenopausal osteoporosis (2016) (278)
- Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. (1988) (276)
- Differential effects of androgens and estrogens on bone turnover in normal men. (2003) (276)
- The Effect of Pregnancy on Bone Density and Bone Turnover (2000) (276)
- Effect of feeding on bone turnover markers and its impact on biological variability of measurements. (2002) (274)
- Measurement of Osteocalcin (2000) (268)
- Association of Five Quantitative Ultrasound Devices and Bone Densitometry With Osteoporotic Vertebral Fractures in a Population‐Based Sample: The OPUS Study (2004) (266)
- International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis (2011) (264)
- Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk (2011) (262)
- Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability (1998) (259)
- Use of bone turnover markers in postmenopausal osteoporosis. (2017) (258)
- WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk (2012) (257)
- Subclinical thyroid dysfunction and fracture risk: a meta-analysis. (2015) (256)
- Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register‐Based National Cohort Study (2009) (250)
- Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis (2004) (247)
- Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. (2014) (243)
- Preanalytical Variability of Biochemical Markers of Bone Turnover (2000) (241)
- Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study (2005) (241)
- Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS) (2003) (236)
- Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. (2004) (230)
- Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. (2008) (229)
- Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. (2005) (219)
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT) (2015) (213)
- Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. (2010) (210)
- Bone turnover markers: use in osteoporosis (2012) (207)
- Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. (2009) (199)
- Glucocorticoid replacement therapy: are patients over treated and does it matter? (1997) (198)
- Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age‐related intestinal resistance to 1,25‐dihydroxyvitamin D action (1991) (198)
- Determinants of Bone Loss in Elderly Men and Women: A Prospective Population-Based Study (1999) (197)
- Biochemical markers of bone turnover in girls during puberty (1994) (196)
- Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines (1999) (195)
- Management of male osteoporosis: report of the UK Consensus Group. (1998) (194)
- Diagnosis and management of bone fragility in diabetes: an emerging challenge (2018) (194)
- Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox. (2012) (194)
- Diagnosis and management of bone fragility in diabetes: an emerging challenge (2018) (194)
- Factors affecting the assay of urinary 3–hydroxy pyridiniurn crosslinks of collagen as markers of bone resorption (1993) (194)
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis (2011) (193)
- Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. (2002) (192)
- The effect of calcium supplementation on the circadian rhythm of bone resorption. (1994) (190)
- Biomarkers of bone health and osteoporosis risk* (2008) (190)
- Efficacy of risedronate on clinical vertebral fractures within six months (2004) (188)
- Health-related quality of life and radiographic vertebral fracture (2004) (186)
- Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density (2004) (184)
- Identification of vertebral fractures: An update (2005) (184)
- Prevalent Vertebral Deformity Predicts Incident Hip though not distal Forearm Fracture: Results from the European Prospective Osteoporosis Study (2001) (182)
- Safety and Efficacy of Risedronate in Reducing Fracture Risk in Osteoporotic Women Aged 80 and Older: Implications for the Use of Antiresorptive Agents in the Old and Oldest Old (2004) (181)
- Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. (2008) (181)
- A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women (2001) (181)
- Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. (2007) (178)
- A Longitudinal Study of Bone Gain in Pubertal Girls: Anthropometric and Biochemical Correlates (1998) (175)
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability (2017) (175)
- Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2‐year results from a randomized trial (2011) (173)
- Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. (2017) (172)
- Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. (2016) (172)
- Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease. (1997) (171)
- Bone Density, Microstructure and Strength in Obese and Normal Weight Men and Women in Younger and Older Adulthood (2015) (167)
- Biochemical Markers as Predictors of Rates of Bone Loss After Menopause (2000) (165)
- Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. (1992) (160)
- The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. (2001) (159)
- Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials (2019) (156)
- Lasofoxifene in postmenopausal women with osteoporosis. (2010) (156)
- Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. (1996) (154)
- Bisphosphonates for postmenopausal osteoporosis. (2011) (153)
- Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS) (2009) (152)
- Histomorphometric and biochemical characterization of bone following acute severe burns in children. (1995) (150)
- Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. (2004) (149)
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States (2009) (149)
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. (2009) (148)
- Age‐Related Changes in Bone Turnover in Men (1999) (147)
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures (2012) (146)
- Establishing a reference range for bone turnover markers in young, healthy women. (2008) (145)
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. (2020) (145)
- Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures (2005) (144)
- Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients (2000) (141)
- Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. (2014) (141)
- Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis (2012) (138)
- Treatment failure in osteoporosis (2012) (136)
- Unequal decrease in bone density of lumbar spine and ultradistal radius in Colles' and vertebral fracture syndromes. (1989) (136)
- Role of oestrogen in the regulation of bone turnover at the menarche. (2005) (135)
- Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. (1991) (135)
- Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. (2010) (133)
- Changes in bone mass and bone turnover following tibial shaft fracture (2005) (128)
- Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption (1993) (128)
- Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. (2020) (128)
- Measuring bone mineral density of the pelvis and proximal femur after total hip arthroplasty. (2001) (127)
- Efficacy and Safety of a Once‐Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older (2010) (127)
- Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. (2010) (126)
- Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole (2008) (126)
- Risk of fractures in patients with pernicious anemia (1992) (124)
- Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once‐yearly zoledronic acid 5 mg: The HORIZON‐Pivotal Fracture Trial (PFT) (2012) (124)
- Changes in Bone Mass and Bone Turnover Following Distal Forearm Fracture (1999) (124)
- Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. (2013) (122)
- Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. (1994) (117)
- Biochemical Markers of Bone Resorption Compared with Estimates of Bone Resorption from Radiotracer Kinetic Studies in Osteoporosis (1997) (117)
- Development of an algorithm for using PINP to monitor treatment of patients with teriparatide* (2006) (117)
- Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis (2017) (116)
- Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. (1996) (115)
- Safety and efficacy of the cathepsin K inhibitor ONO‐5334 in postmenopausal osteoporosis: The OCEAN study (2011) (114)
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis (2009) (113)
- Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study (2015) (112)
- Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study (2009) (112)
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. (2020) (111)
- Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. (2016) (111)
- Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose phase I trial (2010) (110)
- Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. (1992) (109)
- Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. (2016) (109)
- Ethnic and Gender Differences in Bone Mineral Density and Bone Turnover in Young Adults: Effect of Bone Size (2000) (108)
- Effect of Pamidronate in Preventing Local Bone Loss After Total Hip Arthroplasty: A Randomized, Double‐Blind, Controlled Trial (2001) (108)
- Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. (1993) (103)
- Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. (1997) (102)
- Bone Disease after Kidney Transplantation. (2016) (101)
- Erratum: 1991 Classification of vertebral fractures (J Bone Miner Res 6:207-215) (1991) (100)
- Changes in Bone Mass and Bone Turnover Following Ankle Fracture (1999) (99)
- Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab (2013) (98)
- Age related changes in biochemical markers of bone metabolism in horses. (1995) (98)
- Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty (2003) (97)
- Diagnostic value of estimated volumetric bone mineral density of the lumbar spine in osteoporosis (1994) (96)
- Renal safety in patients treated with bisphosphonates for osteoporosis: A review (2013) (96)
- Bone mineral density of the hand in rheumatoid arthritis. (1994) (96)
- 11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. (2003) (95)
- TBS result is not affected by lumbar spine osteoarthritis (2014) (95)
- Octreotide abolishes the acute decrease in bone turnover in response to oral glucose. (2003) (94)
- Polyethylene wear rate and osteolysis: Critical threshold versus continuous dose‐response relationship (2005) (94)
- Proton pump inhibitor use and the antifracture efficacy of alendronate. (2011) (93)
- Biological Variability of Serum and Urinary N‐Telopeptides of Type I Collagen in Postmenopausal Women (2000) (93)
- Clinical usefulness of bone turnover marker concentrations in osteoporosis. (2017) (91)
- Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. (2009) (91)
- International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates (2017) (91)
- Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus. (2013) (90)
- Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. (2010) (89)
- Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. (1999) (88)
- The impact of glucocorticoid therapy on trabecular bone score in older women (2015) (87)
- Proportion of human vertebral body bone that is cancellous (1990) (87)
- Potential Role of Pancreatic and Enteric Hormones in Regulating Bone Turnover (2005) (86)
- Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women. (2007) (86)
- Patient-specific finite element estimated femur strength as a predictor of the risk of hip fracture: the effect of methodological determinants (2016) (86)
- The renal clearance of free and conjugated pyridinium cross‐links of collagen (1996) (86)
- Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. (2014) (86)
- Bone mass and muscle strength in female college athletes (runners and swimmers). (1998) (86)
- Monitoring Alendronate Therapy for Osteoporosis (1999) (85)
- Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. (2012) (85)
- More on reports of esophageal cancer with oral bisphosphonate use. (2009) (85)
- Use of DXA‐based finite element analysis of the proximal femur in a longitudinal study of hip fracture (2013) (84)
- Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. (2007) (84)
- Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine (1997) (84)
- Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period (2019) (83)
- A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women. (2004) (82)
- Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. (1995) (80)
- Risk Factors for Ankle Fracture (2001) (80)
- Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip Arthroplasty (2003) (80)
- The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. (2020) (79)
- The effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women (1997) (79)
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study (2016) (79)
- Management of corticosteroid‐induced osteoporosis (1995) (78)
- Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. (2019) (78)
- One‐day test using stable isotopes to measure true fractional calcium absorption (1989) (78)
- Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies. (2002) (78)
- Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia (1996) (78)
- Precision of EBRA-Digital software for monitoring implant migration after total hip arthroplasty. (2002) (77)
- Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. (2003) (76)
- Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study (2009) (76)
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate: Review of Statistical Analysis (2007) (76)
- Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: A randomized trial (2005) (75)
- Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. (2013) (75)
- Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence (2011) (74)
- Diet and Healthy Bones (2002) (74)
- Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study (2012) (74)
- Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review (2015) (74)
- Effect of stopping risedronate after long-term treatment on bone turnover. (2011) (73)
- Metabolic effects of pamidronate in patients with metastatic bone disease. (1996) (73)
- Phosphate supplementation in young men: lack of effect on calcium homeostasis and bone turnover (1998) (73)
- Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). (2007) (73)
- The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report (2019) (72)
- Reference intervals of bone turnover markers in healthy premenopausal women: results from a cross-sectional European study. (2012) (72)
- Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. (1997) (72)
- Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS) (2010) (72)
- Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial. (2011) (72)
- Visual Identification of Vertebral Fractures in Osteoporosis Using Morphometric X‐ray Absorptiometry (2003) (72)
- Effects of Estrogen Therapy of Postmenopausal Women on Cytokines Measured in Peripheral Blood (1998) (71)
- Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. (1995) (71)
- Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? (2001) (71)
- DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful? (2018) (71)
- Bone mineral density and bone turnover in spinal osteoarthrosis. (1995) (71)
- Use of DXA‐Based Structural Engineering Models of the Proximal Femur to Discriminate Hip Fracture (2009) (70)
- One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density (1999) (70)
- Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. (2008) (70)
- Risk Factors for Vertebral and Nonvertebral Fracture Over 10 Years: A Population‐Based Study in Women (2007) (70)
- Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide (2010) (69)
- Absence of Marked Seasonal Change in Bone Turnover: A Longitudinal and Multicenter Cross‐Sectional Study (2003) (68)
- Identification of Vertebral Deformities in Women: Comparison of Radiological Assessment and Quantitative Morphometry Using Morphometric Radiography and Morphometric X‐Ray Absorptiometry (2000) (68)
- Differential effects of teriparatide on regional bone formation using 18F‐fluoride positron emission tomography (2011) (68)
- The response of the skeleton to physical training: a biochemical study in horses. (1995) (67)
- Effect of ONO‐5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2‐Year Results From the OCEAN Study (2014) (67)
- The effect of a fortified milk drink on vitamin D status and bone turnover in post-menopausal women from South East Asia. (2010) (67)
- Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy. (2018) (67)
- Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials. (2020) (67)
- Algorithm‐Based Qualitative and Semiquantitative Identification of Prevalent Vertebral Fracture: Agreement Between Different Readers, Imaging Modalities, and Diagnostic Approaches (2007) (66)
- Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. (2011) (66)
- Calcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y follow-up. (2008) (65)
- Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? (2014) (64)
- Identification of Vertebral Fracture and Non‐Osteoporotic Short Vertebral Height in Men: The MrOS Study (2007) (64)
- Leptin may play a role in bone microstructural alterations in obese children. (2015) (63)
- Mechanisms of bone loss after cardiac transplantation. (1998) (63)
- Pernicious anaemia as a risk factor for osteoporosis. (1992) (63)
- Prediction of Incident Hip Fracture with the Estimated Femoral Strength by Finite Element Analysis of DXA Scans in the Study of Osteoporotic Fractures (2014) (63)
- Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study (2013) (62)
- Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations (2018) (61)
- Vitamin D status in professional ballet dancers: winter vs. summer. (2013) (60)
- Long-term effects of aromatase inhibitors on bone (2005) (60)
- Esophageal and gastric cancer incidence and mortality in alendronate users (2012) (60)
- Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross‐links: a longitudinal and cross‐sectional study (1992) (59)
- Goal‐directed treatment of osteoporosis (2013) (59)
- Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline. (2002) (58)
- Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis. (2019) (58)
- Denosumab for prevention of fractures in postmenopausal women with osteoporosis. Editorial comment (2009) (57)
- A randomized, controlled dose‐ranging study of risedronate in children with moderate and severe osteogenesis imperfecta (2010) (56)
- Biochemical markers of bone metabolism in growing thoroughbreds: a longitudinal study. (2001) (56)
- Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study (2014) (55)
- Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial. (2014) (55)
- Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts (2018) (54)
- Experimental validation of DXA-based finite element models for prediction of femoral strength. (2016) (53)
- Effects of Depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. (2008) (52)
- Distribution of bone density in the proximal femur and its association with hip fracture risk in older men: The osteoporotic fractures in men (MrOS) study (2012) (52)
- Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high‐bone‐mass phenotype due to a mutation in Lrp5 (2011) (52)
- A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. (1999) (52)
- Recent studies of human calcium metabolism using stable isotopic tracers. (1990) (52)
- Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. (2006) (51)
- BMD changes and predictors of increased bone loss in postmenopausal women after a 5‐year course of alendronate (2013) (51)
- Impact of anomalous vertebral segmentation on measurements of bone mineral density (1993) (51)
- Diclofenac sodium inhibits bone resorption in postmenopausal women. (1994) (51)
- FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study (2013) (50)
- Glucocorticoid-induced osteoporosis. (2001) (49)
- The Performance and Utility of Biochemical Markers of Bone Turnover: Do We Know Enough to Use Them in Clinical Practice? (1997) (48)
- Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice (2006) (48)
- Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression (2018) (48)
- Precision of High-Resolution Peripheral Quantitative Computed Tomography Measurement Variables: Influence of Gender, Examination Site, and Age (2014) (48)
- Comparison of Densitometric and Radiographic Vertebral Fracture Assessment Using the Algorithm‐Based Qualitative (ABQ) Method in Postmenopausal Women at Low and High Risk of Fracture (2007) (47)
- Prediction of bone loss in postmenopausal women (1992) (47)
- Evaluation of serum concentrations of biochemical markers of bone metabolism and insulin-like growth factor I associated with treadmill exercise in young horses. (2003) (47)
- Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial (2010) (47)
- Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. (2000) (46)
- Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study (2013) (46)
- A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. (2009) (46)
- Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis: Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial (2010) (46)
- Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS) (2011) (45)
- Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty (2003) (45)
- Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods. (2014) (45)
- Effi cacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial (2009) (45)
- Vertebral fractures in the elderly may not always be "osteoporotic". (2010) (45)
- Effects of antiresorptive treatment on nonvertebral fracture outcomes (2011) (44)
- Bone Turnover Markers: Use in Fracture Prediction. (2017) (44)
- Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society (2019) (44)
- The Effect of the Cathepsin K Inhibitor ONO‐5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study (2014) (43)
- Bone Turnover in Preterm Infants (1999) (43)
- CHAPTER 67 – Vitamin D and Osteoporosis (1997) (43)
- New approaches to the treatment of osteoporosis. (1987) (43)
- Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures. (2019) (43)
- Bone Markers: Biochemical and Clinical Perspectives (2001) (43)
- Bone fragility in diabetes: novel concepts and clinical implications. (2022) (43)
- Comparison of rates of bone loss from the spine measured using two manufacturers' densitometers (1995) (43)
- Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study (2006) (42)
- Measurement of bone mineral density by dual-energy X-ray absorptiometry around an uncemented knee prosthesis. (1999) (42)
- Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial. (2012) (42)
- Bone loss around 2 different types of hip prostheses. (1998) (42)
- The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study (2005) (41)
- The value of biochemical markers of bone turnover in osteoporosis. (1997) (40)
- Prolonged hypoparathyroidism presenting eventually as second trimester abortion. (1985) (40)
- Individual susceptibility to periprosthetic osteolysis is associated with altered patterns of innate immune gene expression in response to pro‐inflammatory stimuli (2010) (40)
- The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases (2016) (40)
- Geographic and other determinants of BMD change in European men and women at the hip and spine. a population-based study from the Network in Europe for Male Osteoporosis (NEMO). (2007) (39)
- Variation in the secreted frizzled‐related protein‐3 gene and risk of Osteolysis and heterotopic ossification after total hip arthroplasty (2007) (39)
- Plenary Lecture: Strategies for skeletal health in the elderly (2002) (39)
- Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia (2016) (39)
- Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History (2020) (39)
- Distal forearm fracture as risk factor for vertebral osteoporosis (1994) (38)
- Dietary Phosphate Modulates Atherogenesis and Insulin Resistance in Apolipoprotein E Knockout Mice—Brief Report (2011) (38)
- Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts (2017) (38)
- Pain, Quality of Life, and Safety Outcomes of Kyphoplasty for Vertebral Compression Fractures: Report of a Task Force of the American Society for Bone and Mineral Research (2017) (38)
- The role of insulin-like growth factor I in age-related changes in calcium homeostasis in men. (2000) (37)
- Bone Metabolism and Osteoporosis (1998) (37)
- Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption (2014) (37)
- Circadian rhythm of in vitro bone-resorbing activity in human serum. (1995) (37)
- Bone markers and current laboratory assays. (2006) (36)
- An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis (2012) (36)
- Measurement of Bone Adjacent to Tibial Shaft Fracture (2002) (36)
- Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density (2018) (36)
- Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. (2010) (36)
- Diagnostic evaluation of osteoporosis. (1988) (36)
- Very low birth weight survivors have reduced peak bone mass and reduced insulin sensitivity (2011) (35)
- Management of osteoporosis due to ovarian failure. (2003) (35)
- Colles' fracture and bone density of the ultradistal radius. (1990) (34)
- Exercise, hypogonadism, and osteopenia. (1986) (34)
- Colles' fracture and bone density of the ultradistal radius (1989) (34)
- Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice (2013) (34)
- Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density (2010) (34)
- Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. (2019) (33)
- The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) (33)
- Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy (2016) (33)
- The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women. (2006) (33)
- Osteoporosis in men (2013) (32)
- Sex steroids and bone turnover markers in men with symptomatic vertebral fractures. (2008) (32)
- Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort. (2014) (32)
- Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension. (2020) (32)
- Bone remodelling around a cemented polyethylene cup. A longitudinal densitometry study. (2006) (31)
- Bone mineral density of the radius: where do we stand? (1985) (31)
- Biochemical Markers of Bone Turnover and Fracture Prediction (2003) (31)
- Bone turnover markers after the menopause: T-score approach. (2018) (31)
- Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women (2006) (31)
- Forearm fracture. (1996) (30)
- Monitoring alendronate and estradiol therapy with quantitative ultrasound and bone mineral density. (2005) (30)
- Cardiovascular disease and bone. (2010) (30)
- The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women. (2010) (30)
- Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism (2015) (30)
- Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. A trial extension. (2006) (30)
- Total body neutron activation analysis of calcium: calibration and normalisation. (1982) (30)
- Cortical consolidation of the radius and tibia in young men and women. (2012) (30)
- Stable strontium absorption as a measure of intestinal calcium absorption: comparison with the double-radiotracer calcium absorption test. (1994) (29)
- Influence of bone quality on the strength of internal and external fixation of tibial plateau fractures (2006) (29)
- Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease (2016) (29)
- Endocrinology of metabolism (2018) (29)
- To determine the effects of ultraviolet light, natural light and ionizing radiation on pyridinium cross‐links in bone and urine using high‐performance liquid chromatography (1996) (29)
- Anabolic treatment for osteoporosis: teriparatide. (2017) (29)
- The time course of bone fractures observed in the ATAC (‘Arimidex', Tamoxifen, Alone or in Combination) Trial (2003) (29)
- Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study. (2012) (29)
- Total Body and Regional Bone Mineral Density in Men: Effect of Age (1999) (29)
- The Initial Slope of the Variogram, Foundation of the Trabecular Bone Score, Is Not or Is Poorly Associated With Vertebral Strength (2016) (28)
- Measurement of bone specific alkaline phosphatase in the horse: a comparison of two techniques. (1996) (28)
- Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women (2012) (28)
- Effect of age and gender on serum periostin: Relationship to cortical measures, bone turnover and hormones. (2017) (28)
- Effect of light and gamma-irradiation on pyridinolines and telopeptides of type I collagen in urine. (1995) (28)
- Milk supplementation and bone health in young adult chinese women. (2007) (27)
- Risedronate reduces hip fractures in patients with low femoral neck bone mineral density (1999) (27)
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. (2018) (27)
- Developing a toolkit for the assessment and monitoring of musculoskeletal ageing (2018) (27)
- Osteoporosis in rheumatoid arthritis--the laboratory perspective. (1991) (27)
- Biochemical markers of bone turnover. (1999) (27)
- Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis (2019) (27)
- Calcium homeostasis and osteoporosis. (1987) (27)
- Biochemical markers of bone turnover in Paget's disease of bone. (1999) (26)
- Basic science and clinical utility of biochemical markers of bone turnover--a Congress report. (2009) (26)
- Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state. (2014) (26)
- Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures (2020) (26)
- Accuracy and precision of peripheral quantitative computed tomography measurements at the tibial metaphysis. (2004) (26)
- Statistical Shape and Appearance Models in Osteoporosis (2014) (25)
- 2008 Santa Fe Bone Symposium: update on osteoporosis. (2009) (25)
- Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE (2019) (25)
- Serum galactosyl hydroxylysine as a biochemical marker of bone resorption. (1999) (25)
- Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data (2016) (25)
- The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis (1998) (24)
- Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users (2017) (24)
- Erratum: Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the fourth international workshop (Journal of Clinical Endocrinology & Metabolism (2014) 99 (3570-3579) DOI: 10.1210/jc.2014-1414) (2015) (24)
- Significant differences in UK and US female bone density reference ranges (2010) (24)
- Zinc supplementation and bone growth in pubertal girls (1999) (24)
- Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases (1999) (23)
- Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. (1995) (23)
- The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study. (2016) (23)
- A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis. (2005) (23)
- Measurement of bone mass and turnover. (1993) (23)
- ABC of Rheumatology: OSTEOPOROSIS (1995) (23)
- Hormonal determinants of bone turnover before and after attainment of peak bone mass (2010) (22)
- Risk and Prevention of Fracture in Patients With Major Medical Illnesses: A Mini‐Review (2016) (22)
- Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis. (2001) (22)
- Strategies for skeletal health in the elderly. (2002) (22)
- Relationship between risk factors and QUS in a European Population: The OPUS study. (2006) (22)
- Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once‐Yearly ZOL: HORIZON‐PFT Extension Study (2015) (21)
- The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women (2002) (21)
- International variation in proximal femur bone mineral density (2009) (21)
- The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk. (2000) (21)
- Identification of Vertebral Deformities in Men: Comparison of Morphometric Radiography and Morphometric X-ray Absorptiometry (1999) (20)
- A European multicenter comparison of quantitative ultrasound measurement variables: The OPUS study (2012) (20)
- Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood. (2020) (20)
- Site-Specific Bone Measurements in Patients with Ankle Fracture (2002) (20)
- A Vitamin D, Calcium and Leucine-Enriched Whey Protein Nutritional Supplement Improves Measures of Bone Health in Sarcopenic Non-Malnourished Older Adults: The PROVIDE Study (2019) (20)
- The effect of AZD0530, a highly selective, orally available Src/Abl kinase inhibitor, on biomarkers of bone resorption in healthy males (2005) (20)
- Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial (2012) (20)
- Assessment of bone density and bone loss. (1996) (19)
- Effects of calcium-fortified ice cream on markers of bone health (2011) (19)
- Heart drugs that affect bone (2012) (19)
- Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies. (2007) (19)
- Aromatase inhibitors and bone (2007) (18)
- Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone? (1993) (18)
- Short-term Precision for Morphometric X-ray Absorptiometry (2001) (18)
- The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial (2000) (18)
- Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis. (2020) (18)
- Time to onset of antifracture efficacy and year‐by‐year persistence of effect of zoledronic acid in women with osteoporosis (2012) (18)
- Hyponatraemia associated with trimethoprim and a diuretic. (1984) (18)
- Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over (2015) (17)
- Normal levels of total body sodium and chlorine by neutron activation analysis. (1983) (17)
- Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON‐PFT Extension I Trials (2019) (17)
- Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study (2018) (17)
- Variations in vertebral body dimensions in women measured by 3D-XA: a longitudinal in vivo study. (2012) (17)
- The effect of rat parathyroid hormone (1-34) infusion on urinary 3-hydroxypyridinium cross-link excretion in the rat. (1992) (17)
- Managing cancer treatment-induced bone loss: 24-month results from the Study of Anastrozole with the Bisphosphonate RisedronatE (SABRE). (2009) (17)
- Recommendations for the Registration of Agents Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (1996) (17)
- Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis (2018) (17)
- Identification and management of osteoporosis in older adults (2013) (16)
- Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia (2016) (16)
- The nocturnal increase in growth hormone is not the cause of the nocturnal increase in serum osteocalcin. (1991) (16)
- Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study (2012) (16)
- Differential Effects of Primary Hyperparathyroidism on Ultrasound Properties of Bone (2002) (16)
- Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes (2020) (16)
- Commentary: bone density can be used to assess fracture risk. (1999) (16)
- Parathyroid gland hormones in the skeletal development of the ovine foetus: the effect of parathyroidectomy with calcium and phosphate infusion. (1992) (16)
- A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism (2019) (16)
- Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population‐Based Cohort Study (2016) (16)
- Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. (1993) (16)
- Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome. (2013) (16)
- Management of Bone Health in Postmenopausal Women (2005) (15)
- Longitudinal Evaluation of Morphometric X-ray Absorptiometry for the Identification of Vertebral Deformities (2001) (15)
- A Pooled Analysis of Fall Incidence From Placebo‐Controlled Trials of Denosumab (2020) (15)
- Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study (2012) (15)
- Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension (2021) (15)
- Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis (2017) (14)
- Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over (2017) (14)
- Standardised quantitative morphometry: a modified approach for quantitative identification of prevalent vertebral deformities (2007) (14)
- Measurement of Biochemical Markers of Bone Formation (2006) (14)
- Adaptation of the Carter method to adjust lumbar spine bone mineral content for age and body size: application to children who were born preterm. (2006) (14)
- Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from the ocean study (2011) (14)
- Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide (2011) (14)
- Biochemical Assessment Of Skeletal Activity (1995) (14)
- Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results (2008) (14)
- Effect of temperature on the longitudinal variability of quantitative ultrasound variables. (2005) (14)
- The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study. (2019) (13)
- Changes in total body calcium following surgery for primary hyperparathyroidism. (1986) (13)
- The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis. (2020) (13)
- Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. (2005) (13)
- Long-term retention of injected barium-133 in man. (2001) (13)
- Real-world bone turnover marker use: impact on treatment decisions and fracture (2020) (13)
- Bone turnover markers in postmenopausal breast cancer treated with fulvestrant--a pilot study. (2009) (12)
- The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: A systematic review and meta-analysis. (2019) (12)
- Risedronate reduces fracture risk in women with established postmenopausal osteoporosis (1999) (12)
- Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study (2015) (12)
- Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease. (2020) (12)
- Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA‐HD Study Extension (2020) (12)
- Shape, structural properties, and cortical stability along the femoral neck: a study using clinical QCT. (2008) (12)
- Reduction in the risk of clinical fractures after a single dose of zoledronic acid 5 mg (2011) (12)
- Bone gain and loss in premenopausal women. (1993) (12)
- Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians (2018) (12)
- Markers of bone and collagen breakdown in early inflammatory arthritis. (1992) (12)
- Development and validation of a subject-specific finite element model of the functional spinal unit to predict vertebral strength (2017) (12)
- Endogenous Estradiol and The Risk of Incident Fracture in Postmenopausal Women: The OPUS Study (2012) (12)
- Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures (2018) (12)
- Bone Loss from the Hand in Women Following Distal Forearm Fracture (2001) (12)
- Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study (2018) (12)
- Harmonization of commercial assays for PINP; the way forward (2020) (11)
- Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density. (2010) (11)
- The assessment of postmenopausal osteoporosis by total body neutron activation analysis. (1983) (11)
- Comparison of Two Methods for Measuring Ultrasound Properties of the Heel in Postmenopausal Women (2001) (11)
- British Association for the Study of the Liver (1991) (11)
- Raman Spectroscopic Analysis of Fingernail Clippings Can Help Differentiate Between Postmenopausal Women Who Have and Have Not Suffered a Fracture (2016) (11)
- The Effects of Type 1 Diabetes and Diabetic Peripheral Neuropathy on the Musculoskeletal System: A Case–Control Study (2021) (11)
- Changes in total body calcium after renal transplantation: effect of low-dose steroid regime. (1985) (10)
- How to Interpret Surrogate Markers of Efficacy in Osteoporosis (2005) (10)
- Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis (2007) (10)
- Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. (2020) (10)
- Bone turnover markers: a key tool for understanding osteoporosis (2009) (10)
- International Consensus on Diagnosis and Management of Osteonecrosis of the Jaw (2013) (10)
- Raman spectral variation for human fingernails of postmenopausal women is dependent on fracture risk and osteoporosis status (2017) (9)
- Comparison of femoral strength and fracture risk index derived from DXA-based finite element analysis for stratifying hip fracture risk: A cross-sectional study. (2018) (9)
- Treatment of osteoporosis. (1987) (9)
- Reference interval for albumin‐adjusted calcium based on a large UK population (2020) (9)
- Biochemical markers of bone turnover and fracture prediction. (2003) (9)
- Optimization of glucocorticoid replacement therapy: the long‐term effect on bone mineral density (1999) (9)
- Adherence to raloxifene therapy: assessment methods and relationship with efficacy (2013) (9)
- A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring. (2014) (9)
- Tree-structured subgroup analysis of receiver operating characteristic curves for diagnostic tests. (2012) (9)
- A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424 (2018) (9)
- The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis. (1999) (9)
- Biochemical measurements in Paget's disease of bone. (1994) (8)
- Risedronate reduces hip fracture risk in elderly women with osteoporosis (2000) (8)
- Response to Letter to the Editor: Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. (2019) (8)
- Diagnosis of Asymptomatic Primary Hyperparathyroidism : Proceedings of the Society (2009) (8)
- The effect of denosumab treatment on osteoclast precursor cells in postmenopausal osteoporosis (2020) (8)
- Dietary Selenium Intakes and Musculoskeletal Function in Very Old Adults: Analysis of the Newcastle 85+ Study (2020) (8)
- Establishing race-, gender- and age-specific reference intervals for pyridoxal 5'-phosphate in the NHANES population to better identify adult hypophosphatasia. (2020) (8)
- Paget's disease in a patient with ankylosing spondylitis--a diagnostic dilemma. (1996) (8)
- Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained (2020) (8)
- Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus (2016) (8)
- Lipid profiles within the SABRE trial of anastrozole with and without risedronate (2012) (8)
- Biochemical markers of bone turnover in osteoporosis (2013) (8)
- The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids. (2003) (8)
- Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. (2012) (8)
- Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH‐ASBMR SABRE Project (2021) (8)
- Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best? (2020) (8)
- The Renal Clearance of Free and Peptide‐Bound Deoxypyridinoline: Response to Pamidronate Treatment of Paget's Disease (2003) (8)
- Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia (2019) (7)
- Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women. (2009) (7)
- Vertebral Wedge Angle Measured by Morphometric X-ray Absorptiometry (2001) (7)
- Effect of an Aromatase Inhibitor on Bone Mineral Density and Bone Turnover Markers: 2 year Results of the 'Arimidex' (Anastrozole), Tamoxifen, Alone or in Combination (ATAC) trial (2006) (7)
- P20. Urinary excretion of deoxypyridinoline as a marker of bone resorption in the thoroughbred racehorse (1992) (7)
- Is it time to combine osteoporosis therapies? (2013) (7)
- Breast cancer and the risk of osteoporotic fracture: A paradox. (2007) (7)
- Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial (2021) (7)
- Osteoporosis in men. (2022) (7)
- Comparison of polyethylene glycol and chromium-51 chloride as nonabsorbable stool markers in calcium balance studies. (1989) (7)
- MATERNAL GESTATIONAL VITAMIN D SUPPLEMENTATION RESULTS IN GREATER BONE MASS FOR OFFSPRING BORN DURING WINTER MONTHS: THE MAVIDOS MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (2016) (7)
- THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women. (2014) (7)
- Comparison of 3 sequential treatment regimens of teriparatide: Final results from the EUROFORS study (2006) (6)
- Does warfarin increase the risk of osteoporotic fracture? (2006) (6)
- Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial (2015) (6)
- Changes in Bone Turnover and Bone Density after Total Hip Arthroplasty (2000) (6)
- P36. Biomechanical and biochemical changes in cortical allograft bone after gamma irradiation (1996) (6)
- Classical and Nonclassical Manifestations of Primary Hyperparathyroidism (2022) (6)
- Sulfasalazine may interfere with HPLC assay of urinary pyridinium crosslinks. (1994) (6)
- Pleiotropic associations of heterozygosity for the SERPINA1 Z allele in the UK Biobank (2021) (6)
- Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. (2016) (6)
- Optimal Thresholds, Linear or Nonlinear Relationships of Fracture Risk Reduction With Therapy (2008) (6)
- Performance of quantitative ultrasound measurements of bone for monitoring raloxifene therapy. (2010) (6)
- Supine vs decubitus lateral patient positioning in vertebral fracture assessment. (2012) (6)
- Rate of bone loss from lumbar spine in women with distal forearm fracture (1996) (6)
- Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study (2020) (6)
- Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with ostoporosis : 4-year results from the MORE trial (2001) (5)
- EFFECTIVENESS OF MATERNAL VITAMIN D SUPPLEMENTATION: A MULTICENTRE RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL (MAVIDOS) (2015) (5)
- Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial (2022) (5)
- 1211 Randomised double-blind comparison of pamidronate or clodronate for hypercalcaemia of malignancy: Effects on bone metabolism markers (1995) (5)
- Effect of denosumab on osteolytic lesion activity after total hip arthroplasty: a single-centre, randomised, double-blind, placebo-controlled, proof of concept trial (2021) (5)
- A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM) (2021) (5)
- A History of Pivotal Advances in Clinical Research into Bone and Mineral Diseases (2018) (5)
- Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports (2022) (5)
- Bone Turnover Markers: Their Place in the Investigation of Osteoporosis (2002) (5)
- Poster 150: Effect of Once-Yearly Infusion of 5mg of Zoledronic Acid in Postmenopausal Women With Osteoporosis: The HORIZON-Pivotal Fracture Trial (2007) (5)
- Defining a “Reference Population”: No Easy Task (2009) (5)
- Bone: Microarchitecture of bone predicts fractures in older women (2018) (5)
- The central role of the skeleton in chronic diseases. (2010) (5)
- Effect of Pamidronate on Excretion of Pyridinium Crosslinks of Collagen After Total Hip Arthroplasty (2003) (5)
- The role of calcium and exercise in the prevention of postmenopausal osteoporosis (1993) (4)
- Bone Turnover Markers: Basic Biology to Clinical Applications. (2022) (4)
- Do patients receive appropriate information and treatment following bone mineral density measurements? (2002) (4)
- Subtrochanteric and diaphyseal fractures in patients during long-term alendronate treatment: Expanded and extended national register based cohort study (2010) (4)
- Bisphosphonates and the risk of atypical femur fractures (2021) (4)
- Measurement of Intestinal Calcium Absorption by Using Stable Strontium: Author's Reply (1995) (4)
- A primed-infusion technique for rapid estimation of the metabolic clearance rate of 1,25(OH)2D3. (1987) (4)
- 5. An International Multicenter Randomized Comparison of Balloon Kyphoplasty and Non-Surgical Management in Patients with Acute Vertebral Body Compression Fractures (2007) (4)
- The effect of age on bone collagen turnover as assessed by pyridinium crosslinks and procollagen I C-terminal peptide (2005) (4)
- P43. Impact of variations in spinal segmentation on bone mineral density measurements (1992) (4)
- Maternal pregnancy vitamin D supplementation increases offspring bone formation in response to mechanical loading: Findings from a MAVIDOS Trial sub-study (2020) (4)
- Efficacy of risedronate in decreasing the incidence of femoral neck and intertrochanteric fractures in older women with osteoporosis (2001) (4)
- Type I collagen degradation during tissue repair: comparison of mechanisms following fracture and acute coronary syndromes. (2014) (4)
- Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal women (1999) (4)
- A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Care for Acute Vertebral Compression Fracture (2009) (4)
- Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis (2021) (3)
- Precision of periprosthetic bone mineral density measurements using Hologic Windows versus DOS-based analysis software. (2006) (3)
- Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. Reply. (2020) (3)
- The response of bone turnover markers to lasofoxifene: The PEARL trial (2009) (3)
- Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study (2022) (3)
- Prevention and management of osteoporosis (2017) (3)
- Response to Letter to the Editor: “Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History” (2020) (3)
- EPIDEMIOLOGY OF FALLS AMONG 11009 ELDERLY MEN - THE MR OS STUDY (2010) (3)
- 740 Placebo-controlled trial of vitamin K supplementation on bone mineral density in primary biliary cirrhosis(PBC) (2003) (3)
- A Spatio-Temporal Ageing Atlas of the Proximal Femur (2020) (3)
- THE INFLUENCE OF SEX ON MORPHOMETRIC INDEXES OF VERTEBRAL DEFORMITY (1993) (3)
- Effect of once-yearly zoledronic acid 5 mg on ‘Super Six’ non-vertebral fractures (2009) (3)
- Effects of Feeding on Bone Metabolism (2009) (3)
- Effect of age and gender on bone turnover markers: relationships with oestradiol and parathyroid hormone (2011) (3)
- Type I collagen isomerization (alpha/beta CTX ratio) and the risk of hip and non-spine fracture in men: A prospective study (2009) (3)
- Biomarkers of Disease: Bone turnover markers in clinical practice (2002) (3)
- Interaction between body mass index and bone turnover during aromatase inhibition: Evidence from the letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial (2007) (3)
- Role of estrogen in the age-related decline in bone microstructure. (2013) (3)
- Effect of risedronate on collagen cross links in postmenopausal osteoporosis (1995) (3)
- Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial (2021) (3)
- Reply to letter by Gallo and Petrek commenting on interleukin-1 receptor antagonist and interleukin-6 polymorphisms and post-total hip arthroplasty osteolysis. (2009) (3)
- The Role of Static Bone Histomorphometry in Diagnosing Renal Osteodystrophy. (2020) (3)
- Total 24-hour pyridinium crosslink excretion correlates with cancellous bone resorption rate (1992) (3)
- Proceedings: Impedance change to differing heart rate and cardiac output across the acutely stenosed aortic valve. (1975) (3)
- Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation). (2022) (3)
- Time to onset of anti-fracture efficacy and persistence of effect of zoledronic acid 5 mg in women with osteoporosis or recent hip fracture (2009) (3)
- Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant. (2007) (3)
- P35. Prevalence of vertebral deformities in Sheffield, UK (1994) (2)
- A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results (2022) (2)
- Relation of diurnal rhythm of cortisol to bone-resorbing activity in human serum (1993) (2)
- Response Letter to the Editor—Diamond et al, JBMR (2019) (2)
- Re-initiation of risedronate 5 mg daily therapy in patients on long-term treatment after 1 year of discontinuation: effects at 9 and 10 years (2010) (2)
- Measurement of spinal calcium by in vivo neutron activation analysis in osteoporosis. (1981) (2)
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON‐Pivotal Fracture Trial (PFT) (2012) (2)
- Chapter 36. Vertebral Fracture Assessment (2009) (2)
- O29 Bone turnover in pregnancy, measured by urinary C-terminal telopeptide of type I collagen (CTX), is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the MAVIDOS trial (2019) (2)
- Effect of selenium supplementation on biomarkers of bone turnover (2021) (2)
- The effect of fracture heating on biochemical markers of bone turnover (1995) (2)
- Diclofenac sodium prevents bone loss at the lumbar spine and femoral neck in idiopathic osteoporosis (1992) (2)
- Continuation of Bisphosphonate Therapy for Osteoporosis beyond 5 Years. (2022) (2)
- A case control study of sex steroids and bone turnover in men with symptomatic vertebral fractures (2001) (2)
- Offset of effect on bone resorption after 7 years of risedronate therapy (2009) (2)
- Are patients treated with oral bisphosphonates at increased risk of esophageal cancer (2009) (2)
- A double-blind, placebo-controlled study to determine the effects of risedronate on bone loss in glucocorticoid-treated rheumatoid arthritis patients (2006) (2)
- A SINGLE NUCLEOTIDE POLYMORPHISM AT – 238 IN THE TNF GENE INFLUENCES PROMOTER RESPONSE TO POLYETHYLENE PARTICLES IN-VITRO (2004) (2)
- Modern spectrum of bone turnover markers - are they clinically useful? (2017) (2)
- SUN-622 The Risk of Hip and Non-Vertebral Fractures in Diabetes: A Systematic Review and Meta-Analysis Update (2020) (2)
- Calcium Requirements During Treatment of Osteoporosis in Women (2005) (2)
- Effects of raloxifene on bone mineral density and biochemical markers of bone turnover in postmenopausal women with osteoporosis : 4-year results from the MORE trial (2000) (2)
- Personalised 3D Assessment of Trochanteric Soft Tissues Improves HIP Fracture Classification Accuracy (2022) (2)
- FP638PERIPHERAL VASCULAR CALCIFICATION AND BONE CHANGES IN ADVANCED CHRONIC KIDNEY DISEASE USING HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (HR-pQCT) (2015) (2)
- P14. Circadian changes in bone turnover assessed by serum bone gla-protein and urinary deoxypyridinoline: effect of growth and ageing (1990) (2)
- Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk (2022) (2)
- CHAPTER 32 – Measurement of Biochemical Markers of Bone Formation (2006) (2)
- Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng (2017) (2)
- Calcium, protein, and phosphorus intakes and bone density. (1994) (2)
- Hypothalamic-pituitary-adrenal axis. Discussion (1994) (2)
- Bone turnover in pregnancy, measured by urinary C-terminal telopeptide of type I collagen (CTX), is influenced by vitamin D supplementation and is associated with maternal bone health: Findings from the MAVIDOS trial. (2021) (2)
- Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium (2020) (2)
- Adaptation of Young Men to High Phosphate Intake (1998) (2)
- Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant (2006) (2)
- Effect of Once-Yearly Zoledronic Acid 5 Mg on A Sub-Set of Six Non-Vertebral Fractures (2010) (2)
- Pleiotropic effects of heterozygosity for the SERPINA1 Z allele in the UK Biobank (2020) (2)
- Daily nitroglycerin increases bone formation, bone mass, bone structure, and indices of bone strength: A two-year randomized trial (2011) (1)
- 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial (2023) (1)
- Denosumab increases total, trabecular, and cortical estimated hip and spine strength in postmenopausal women with osteoporosis (2011) (1)
- Zoledronic Acid Substantially Reduces the Risk of Morphometric Vertebral and Clinical Fractures (2010) (1)
- EFFECT OF GENETIC POLYMORPHISM ON THE SEVERITY OF OSTEOLYTIC BONE DEFECTS IN ASEPTIC LOOSENING (2010) (1)
- Towards a toolkit for the assessment and monitoring of musculoskeletal ageing (2018) (1)
- EFFECT OF PAMIDRONATE ON BONE LOSS AND IMPLANT MIGRATION AFTER THA. A 2 YEAR RANDOMISED TRIAL (2003) (1)
- Higher bone resorption excretion in South Asian women vs. White Caucasians and increased bone loss with higher seasonal cycling of vitamin D: Results from the D-FINES cohort study. (2017) (1)
- Once-yearly treatment with zoledronic acid continues to be effective in old age (2009) (1)
- Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice: Reply to comment by Pluskiewicz and Drozdzowska (2007) (1)
- OP16Effect of denosumab on bone turnover markers in postmenopausal osteoporosis: Initial response and subsequent release from suppression (2009) (1)
- A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Care for Acute Vertebral Fracture: Who Responds Best? (2008) (1)
- Development of a Hypoparathyroid Male Rodent Model for Testing Delayed-Clearance PTH Molecules. (2021) (1)
- THRA and DIO 2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women (2014) (1)
- A Phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of Burosumab, an anti-FGF23 antibody, in adult X-Linked Hypophosphatemia (XLH) (2018) (1)
- The risk of oesophageal and gastric cancer incidence and mortality in alendronate users: National cohort study (2011) (1)
- CALCIUM, PROTEIN, AND PHOSPHORUS INTAKES AND BONE DENSITY. AUTHORS' REPLY (1994) (1)
- Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland. (2019) (1)
- The effect of bisphosphonate therapy on serum levels of pyridoxal-5 phosphate: relevance to atypical femur fractures (2015) (1)
- Bone Turnover Markers (2003) (1)
- The effect of 3 orally-administered bisphosphonates on the resorption of type I collagen in postmenopausal osteoporosis (2010) (1)
- 24-hour growth hormone profiles and bone density in elderly men (1995) (1)
- Efficacy and safety of the cathepsin K inhibitor, ONO-5334, in the treatment of postmenopausal osteopenia or osteoporosis (2010) (1)
- The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis (2010) (1)
- Calcium and bone mineral accretion in teenage girls: a review. (2001) (1)
- Reduced risk of colon cancer death in patients treated with alendronate - National register based cohort study (2010) (1)
- The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis (2022) (1)
- Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women (2021) (1)
- P3. Clinical evaluation of a radioimmunoassay for the measurement of deoxypyridinoline in urine and serum (1996) (1)
- Effect of previous bisphosphonate use on response to zoledronic acid: Results from the HORIZON-PFT study (2008) (1)
- Childhood astham and growth : a review of the literature. Discussion (1994) (1)
- Determinants of bone turnover marker response to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study (2014) (1)
- Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial (2021) (1)
- Risedronate is well-tolerated in women with osteoporosis (1999) (1)
- AFTER 3 YEARS OF ANNUAL ZOLEDRONIC ACID, WHO SHOULD REMAIN ON TREATMENT? RESULTS FROM THE HORIZON-PFT EXTENSION STUDY (2012) (1)
- Effects of inhaled steroids on bone mineral density: Are the conclusions misleading? (2001) (1)
- Long‐Term Selenium‐Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo‐Controlled Trial (2022) (1)
- Posterior pituitary gland (2018) (1)
- Improving the Hip Fracture Risk Prediction with a Statistical Shape-and-Intensity Model of the Proximal Femur (2022) (1)
- Densitometric vertebral fracture assessment using the algorithm-based qualitative method: Baseline fracture predicts incident vertebral fracture at 6-year follow-up (2011) (1)
- G59 Bone microarchitecture and strength in obese children – a new insight into fracture risk (2014) (1)
- Investigating suspected osteoporosis (2006) (1)
- Relationships between osteoporosis medication adherence, surrogate marker outcomes and non-vertebral fracture incidence (2010) (1)
- Identification of responders to teriparatide therapy by procollagen Type I N-Propeptide (P1NP) using the least significant change approach (2005) (1)
- Pathogenesis of Transplantation Bone Disease: A Unifying Hypothesis (2005) (1)
- Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials (2019) (1)
- Statins and Bone (2003) (1)
- Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia (2022) (1)
- EFFECT OF 6-YEAR TREATMENT OF OSTEOPOROSIS WITH ZOLEDRONIC ACID 5MG (ACLASTA) COMPARED WITH THE 3-YEAR-TREATMENT, RESULTS OF EXTENDED HORIZON PFT STUDY (2012) (1)
- Risedronate prevents the first vertebral fracture in at-risk postmenopausal women. (2000) (1)
- Bone-specific biochemical marker: of turnover in multiple myeloma (1995) (1)
- Variability and Response of Urinary Resorption Markers to Hormone Replacement Therapy (1999) (1)
- One year effect of anastrozole and risedronate on bone mineral density: First results from the IBIS-II bone sub-study (2011) (1)
- What accounts for an inadequate response to zoledronic acid (2010) (1)
- Bone mineral density (BMD) measurements by photon absorptiometry (PA). An overview. (1986) (1)
- Seasonal Variation Present and Biologically Significant? (2003) (1)
- Rate of Loss Recalculated (1999) (1)
- 3. Biochemical markers of bone remodelling in the study of osteoporosis (1994) (1)
- Longitudinal changes of bone mineral density in primary hyperparathyroidism (1995) (1)
- Circadian rhythms of bone resorption in normal women and women with postmenopausal osteoporosis using deoxypyridinoline (1990) (1)
- Maternal pregnancy vitamin D supplementation is associated with greater offspring bone mineral density at 4 years: findings from the MAVIDOS trial (2019) (1)
- Guidelines for management of male osteoporosis (2011) (1)
- Spatio-Temporal Atlas of Bone Mineral Density Ageing (2018) (1)
- SAT-408 Bioactivity of Long Acting PTH Fusion Molecules Tested in a Novel Non-Surgical Animal Model of Hypoparathyroidism (2020) (0)
- SERUM C-TELOPEPTIDE OF TYPE-I COLLAGEN, A MATRIX METALLOPROTEINASE-DERIVED COLLAGEN DEGREDATION PRODUCT, IS A SENSITIVE BIOMARKER FOR DETECTING PERIPROSTHETIC OSTEOLYSIS (2011) (0)
- Clinical Endocrinology Trust Award 2020 – Biography (2020) (0)
- GENETIC VARIATION IN THE TNF GENE AND ASEPTIC LOOSENING AFTER TOTAL HIP ARTHROPLASTY (2003) (0)
- P14. Long term variability of markers of bone turnover in healthy postmenopausal women (1996) (0)
- The effect of daily calcium-fortified ice cream on bone turnover and parathyroid hormone in young women taking a diet low in calcium (2010) (0)
- BONE AGEING ATLAS DEVELOPMENT: THE UK BIOBANK STUDY (2019) (0)
- DXA REGION FREE ANALYSIS COULD ENHANCE FRACTURE PREDICTION BEYOND NECK BONE MINERAL DENSITY (2020) (0)
- Response to letter relating to Gossiel F, Paggiosi MA, Naylor KE, et al. The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: the T-score bone marker approach in the TRIO study. (2020) (0)
- A rare presentation of avascular necrosis of the femoral head and mild cardiomyopathy in a patient with 17-hydroxylase deficiency (2022) (0)
- Phase II study of the impact of AZD4017, a selective 11β-HSD1 inhibitor, on osteocalcin in post-menopausal osteopenia (2020) (0)
- PREMENOPAUSAL MIGRANT SOUTH ASIAN WOMEN HAVE HIGHER URINARY N-TELOPEPTIDE THAN WOULD BE EXPECTED FOR THEIR AGE (2014) (0)
- Fracture risk reduction with zoledronic acid by predicted fracture risk score (2011) (0)
- Endogenous Estradiol and The Risk of Incident Fracture in Postmenopausal Women: The OPUS Study (2012) (0)
- The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft. (2011) (0)
- Personalised treatment of osteoporosis (2012) (0)
- Endocrine disorders in pregnancy (2018) (0)
- Biochemical bone metabolism responses in glucocorticoid-treated rheumatoid arthuritis patients following risedronate therapy (2006) (0)
- URINE C-TERMINAL TELOPEPTIDE OF TYPE I COLLAGEN (CTX) IN PREGNANCY IS INFLUENCED BY VITAMIN D SUPPLEMENTATION AND IS ASSOCIATED WITH MATERNAL BONE HEALTH: FINDINGS FROM THE MAVIDOS TRIAL (2018) (0)
- Hyponatraemia Associated With Trimethoprim and a Diuretic (1985) (0)
- OC05: VARIATION IN THE INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE PROTECTS AGAINST OSTEOLYSIS AFTER TOTAL HIP ARTHROPLASTY: A CLINICAL AND GENE EXPRESSION STUDY (2010) (0)
- Vitamin D levels in type 1 diabetes with and without neuropathy; A case-control study (2021) (0)
- PREDICTORS OF SECOND FRACTURE WHILE ON TREATMENT WITH ORAL BISPHOSPHONATES: A MULTINATIONAL RETROSPECTIVE COHORT STUDY (2014) (0)
- Author response for "Bone turnover markers do not predict fracture risk in type 2 diabetes" (2020) (0)
- Correction to: A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM) (2021) (0)
- Phase I/III study to confirm bioequivalence and safe switching of proposed biosimilar denosumab in postmenopausal osteoporosis (2020) (0)
- Patient advice and reference (2018) (0)
- Differential Effects Of Teriparatide On Trabecular And Cortical Bone Measured By 18 F-Fluoride Positron Emission Tomography (2012) (0)
- Thyroid hormones in the euthyroid range predict subsequent body mass composition in women: the OPUS study (2011) (0)
- Acute regulation of bone collagen turnover and PTH by insulin and glucose: Hyperinsulinemic euglycaemic and hypoglycaemic clamp studies (2001) (0)
- THE PREVALENCE AND NATURAL HISTORY OF NORMOCALCAEMIC HYPOPARATHYROIDISM IN A UNITED KINGDOM REFERRAL POPULATION Short title: NHYPO: Prevalence and natural history (2020) (0)
- Corrigendum (1991) (0)
- World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Satellite Symposium Abstracts (2014) (0)
- The association in men and women between Growth Differentiation Factor 15, bone density and bone turnover (2022) (0)
- Use of sodium-glucose co-transporter-2 inhibitors, changes in body mass index and risk of fracture: The clinical practice research datalink gold (2020) (0)
- 92208129 Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: A longitudinal and cross-sectional study (1993) (0)
- Transdermal testosterone replacement in men with evidence of borderline gonadal failure (2004) (0)
- Inherited endocrine syndromes and multiple endocrine neoplasia (2018) (0)
- FP610VASCULAR CALCIFICATION IN ADVANCED CKD AND ITS RELATIONSHIP WITH BONE MICROSTRUCTURES (2019) (0)
- Diagnostic discrimination of TBS and spine BMD in glucocorticoid-induced and postmenopausal osteoporosis (2013) (0)
- SUBCLINICAL THYROID DYSFUNCTION AND FRACTURE RISK : AN INDIVIDUAL PARTICIPANT DATA ANALYSIS OF PROSPECTIVE COHORTS (2014) (0)
- What is the relationship between testosterone and fat mass in young male cancer survivors and healthy controls (2006) (0)
- Radius bone loss with ageing assessed by high-resolution peripheral computed tomography differs in men and women (2011) (0)
- Calcium and bone metabolism (2021) (0)
- 13. Validation of collagen crosslinks as markers of bone resorption: comparison with radioisotopic method (1991) (0)
- The percentage reduction in vertebral fracture risk with lasofoxifene explained by change in spine bone mineral density (2010) (0)
- PHARMACOLOGICAL PREVENTION OF PERIPROSTHETIC BONE LOSS AFTER TOTAL HIP ARTHROPLASTY: A RANDOMISED TRIAL. (2003) (0)
- Poor Health May Predict Vertebral Fractures but Not Non-vertebral Fractures (2004) (0)
- The effect of bisphosphonate treatment on bone turnover and bone balance in postmenopausal women with osteoporosis (2015) (0)
- Bone mineral density and biochemical marker response rates in postmenopausal women after treatment with zoledronic acid (2008) (0)
- A Vitamin D, Calcium and Leucine-Enriched Whey Protein Nutritional Supplement Improves Measures of Bone Health in Sarcopenic Non-Malnourished Older Adults: The PROVIDE Study (2019) (0)
- Cancellous bone loss during pregnancy is a consequence of high bone remodelling (1998) (0)
- The long-term safety and efficacy of zoledronic acid in the treatment of osteoporosis: a 3-year, randomized extension to the HORIZON-pivotal fracture trial (PFT) (2011) (0)
- The prevalence and natural history of normocalcaemic hypoparathyroidism in a United Kingdom referral population (2020) (0)
- OSTEOBLAST ACTIVITY MARKERS PREDICT DEVELOPMENT OF HETEROTOPIC OSSIFICATION AFTER THA (2002) (0)
- Erratum: Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose phase I trial (2012) (0)
- ASSOCIATION BETWEEN DEGREE OF SEASONAL FLUCTUATION (‘CYCLING’) OF 25(OH)D, PTH AND BONE RESORPTION IN UK SOUTH ASIAN AND CAUCASIAN WOMEN LIVING AT 51ON (SURREY) (2010) (0)
- Biological activity in nonunions (1999) (0)
- Rate of change in lumbar spine bone mineral density in women with distal forearm fracture (1995) (0)
- Relationship between change in total hip BMD in response to zoledronic acid 5 mg and pre-treatment change in total hip BMD: The HORIZON-PFT Extension study (2012) (0)
- Glucocorticoid receptor antagonism as a decision making tool in patients with adrenal incidentaloma and low-grade excess cortisol secretion: a pilot study (2011) (0)
- Hip fracture in older women: Association with hip structure by DXA (2011) (0)
- Relationship between serum IGF-I and fracture types in postmenopausal women (2012) (0)
- 200 – Biochemical markers in bone disease (2015) (0)
- EffectofNitroglycerinOintmentonBoneDensity and Strength in Postmenopausal Women (2016) (0)
- Bone loss from the skull in response to teriparatide therapy: regional differences in response to anabolic osteoporosis therapy (2015) (0)
- P59. Disease severity as a determinant of rates of bone loss and bone turnover in early rheumatoid arthritis (1994) (0)
- Reply (1991) (0)
- Pregnancy vitamin D supplementation leads to greater offspring bone mineral density at age 4 years: findings from the MAVIDOS trial (2021) (0)
- Determining the Effects of Race, Skin Colour, and Genotype on the Response to Vitamin D Therapy (2015) (0)
- PLASMA CTX IN PREGNANCY IS ALTERED BY CHOLECALCIFEROL SUPPLEMENTATION AND IS ASSOCIATED WITH MATERNAL BONE INDICES: THE MAVIDOS TRIAL (2018) (0)
- Late effects of very low birth weight on bone mass at the lumbar spine (2005) (0)
- Evidence for an Association Between Seasonal Fluctuation of 25(OH)D and Serum C-telopeptide (CTx): Preliminary Evidence from the D-FINES study. (2011) (0)
- Dietary phosphate as a risk factor for osteoporosis (1995) (0)
- Response to Teriparatide Treatment Differs by Anatomical Site and Bone Compartment (2016) (0)
- Depot Medroxyprogesterone Acetate Use is Associated with a Bone Density Deficit in Young Adult Women (2004) (0)
- Does bone density, bone strength, sarcopenia or dynapenia explain greater risk of fracture in obesity? (2014) (0)
- Meeting report from the national osteoporosis foundation 5th international symposium on clinical advances in osteoporosis (2002) (0)
- DXA-based finite element models for prediction of femoral strength: validation with experiments and comparison with aBMD and QCT-based finite element models (2015) (0)
- Adrenal gland (2018) (0)
- Surrogate markers for the effect of antiresorptive therapies on non-vertebral fractures - a critique (2002) (0)
- DIFFERENCES IN IMMUNE RESPONSES BETWEEN SUBJECTS WITH PREVIOUS ASEPTIC LOOSENING VERSUS SURVIVING THA (2009) (0)
- Authors' Reply. (2018) (0)
- Comparison of treatment responder rates for three oral bisphosphonates: The TRIO study (2020) (0)
- Response to: Some Questions About the Article “The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report” (2019) (0)
- A Placebo Controlled Randomized Trial of Chromium Picolinate Supplementation on Indices of Bone and Calcium Metabolism in Healthy Women (2004) (0)
- Primary hyperparathyroidism: epidemiology and diagnosis (2014) (0)
- Disorders of gender and fertility (2018) (0)
- P32. Relationship of bone mineral density to age in men (1996) (0)
- Bone resorption levels are related to diet in UK dwelling South Asian but not Caucasian women (2015) (0)
- Effect of Previous Bisphosphonate Use on Response to Zoledronic Acid (2008) (0)
- O13 Pregnancy vitamin D supplementation leads to greater offspring bone mineral density at 4 years: the MAVIDOS randomised placebo controlled trial (2020) (0)
- Dietary selenium intakes and their association with muscle strength and function in ≥ 85 year old adults: the Newcastle 85 + Study (2020) (0)
- Prediction of incident hip fracture with femoral strength assessed by finite element analysis of DXA scans in the osteoporotic fractures in men (MrOS) study (2015) (0)
- Overview of clinical research methods to study osteoporosis (2011) (0)
- Speedy reference (2018) (0)
- EFFECT OF PAMIDRONATE ON CLINICAL OUTCOME, BONE LOSS AND OSTEOLYSIS OVER 5 YEARS AFTER THA (2006) (0)
- Investigation of metabolic bone disease by in vivo neutron activation analysis (1984) (0)
- Diurnal and weekly variability in serum levels of bone-related circulating microRNAs (2020) (0)
- PP-8-17 Biochemical markers of bone resorption predict response to bisphosphonate treatment (1996) (0)
- Vitamin D supplementation in pregnancy leads to greater bone mass in UK infants born during winter months: the MAVIDOS multicentre, randomised, double-blind, placebo-controlled trial (2016) (0)
- Development of the Bone Phenotype and microRNA Profile in Adults With Low‐Density Lipoprotein Receptor‐Related Protein 5–High Bone Mass (LRP5‐HBM) Disease (2021) (0)
- Which DXA sites to choose for prospective fracture risk assessment? Comparison of different guidelines based on data from the opus study (2009) (0)
- Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-Propeptide (PINP) (2010) (0)
- Committees and Contact Information (2008) (0)
- Bone mass at the lumbar spine in young adults: Late effects of very low birth weight. (2005) (0)
- Biochemical monitoring of teriparatide efficacy in a real world setting (2016) (0)
- 29. Evaluation of new bone resorption markers in a comparison of pamidronate or clodronate for hypercalcaemia of malignancy (1995) (0)
- Biochemical evidence of antiresorptive effect of risedronate in established osteoporosis (2006) (0)
- Serum bone markers in healing tibial fractures (1996) (0)
- Serum 25(OH)D Deficiency in Young Adults is Associated with Low Dietary Vitamin D Intake and a Shorter 25(OH)D3 Half-Life (2015) (0)
- MON-537 Fusion of Parathyroid Hormone to Growth Hormone Binding Protein Delays Clearance Whilst Retaining Biological Activity (2019) (0)
- Thyroid hormone metabolism (2018) (0)
- Effect of thyroid status on the skeleton in post-menopausal women: the OPUS study (2008) (0)
- Seasonal fluctuation in vitamin D status is associated with indices of bone health in UK South Asian but not Caucasian women living at 51°N (2010) (0)
- INDIVIDUALISED FINITE ELEMENT MODEL PREDICTS FEMORAL FRACTURES MORE ACCURATELY THAN CURRENT CLINICAL INDICATORS (2014) (0)
- A randomised double-blind cross-over study of GH treatment in patients over 60 years (2003) (0)
- Precision of High-Resolution Peripheral Quantitative Computed Tomography Measurement Variables: Influence of Gender, Examination Site, and Age (2013) (0)
- FRIZZLED-RELATED PROTEIN 3 GENE POLYMORPHISM AND RISK OF OSTEOLYSIS (2006) (0)
- Risedronate significantly reduces vertebral and non-vertebral fractures in osteoporotic women (1999) (0)
- MEASUREMENT OF PERIPROSTHETIC BONE MINERAL DENSITY USING WINDOWS VERSUS DOS BASED ANALYSIS SOFTWARE. (2006) (0)
- TNFα AND IL-1β CYTOKINE MRNA EXPRESSION IN POLYETHYLENE STIMULATED MACROPHAGES (2006) (0)
- Markers of bone turnover and disease status in prostate cancer (2003) (0)
- THRA or DIO2 mutations are not a common cause of high bone mass in humans (2013) (0)
- Pituitary gland (2018) (0)
- Endocrinology of different age groups (2018) (0)
- HOW DOES THE INITIAL SLOPE OF THE VARIOGRAM, THE TEXTURAL BASIS OF THE TRABECULAR BONE SCORE, PREDICT VERTEBRAL STRENGTH? (2016) (0)
- Syddansk Universitet Risk of hip , subtrochanteric , and femoral shaft fractures among mid and long term users of alendronate nationwide cohort and nested case-control study (2016) (0)
- A simple low-magnesium diet. (1980) (0)
- Introduction to the Bisphosphonate Special Issue. (2023) (0)
- Vertebral fracture risk reduction is independent of the magnitude of BMD change (2004) (0)
- Monitoring anti-resorptive treatments for osteoporosis using bone turnover markers (2012) (0)
- The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal women with rsteoporosis: The TRIO study (2014) (0)
- MicroRNAs in diabetic bone disease: A systematic review (2021) (0)
- The relationship between bone regulatory markers and bone turnover in renal osteodystrophy (2020) (0)
- Subject Index Vol. 67, Suppl. 1, 2007 (2007) (0)
- O2312 THE INFLUENCE OF BONE DENSITY ON THE FIXATION STRENGTH OF BICONDYLAR TIBIAL PLATEAU FRACTURES – AN IN VITRO MECHANICAL STUDY (2004) (0)
- Increases in proximal femur bone strength estimated using finite element models from computed tomography scans following brief, high impact exercise in older men [Abstract] (2016) (0)
- Denosumab after total hip arthroplasty – Authors' reply (2021) (0)
- Effect of age and gender on serum growth differentiation factor 15 and its relationship to bone density and bone turnover. (2023) (0)
- Leptin is associated with bone microstructural changes in obese children (2014) (0)
- Author response for "Validation of the Surrogate Threshold Effect for Change in BMD as a Surrogate Endpoint for Fracture Outcomes: the FNIH‐ASBMR SABRE Project" (2021) (0)
- THE MECHANICAL STRENGTH AND GEOMETRIC AND DENSITOMETRIC PARAMETERS OF PQCT SCAN (2005) (0)
- Medico-legal aspects (2018) (0)
- Risk Assessment and Fracture Discrimination by Ultrasound: The Debate Continues (2005) (0)
- Statins for the prevention of postmenopausal osteoporosis (2002) (0)
- Vitamin D is low in obesity, and this is due to greater volume of distribution (2014) (0)
- To buckle or not to buckle: A finite element modelling of the proximal femur (2009) (0)
- The effect of risedronate on hip fracture risk in elderly women with osteoporosis (2001) (0)
- Diurnal Changes in Serum Levels of Bone-Related Circulating MicroRNAs (2020) (0)
- Bisphosphonates and colon cancer: reply (2013) (0)
- Low Bone Turnover Associates with Lower Insulin Sensitivity in Newly Diagnosed Drug-naïve Persons with Type 2 Diabetes. (2023) (0)
- Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – ECCEO 9 – IOF (2009) (0)
- A calcaneal quantitative ultrasound quality control phantom for cross-calibration and highly precise longitudinal stability tests (2009) (0)
- Effect of Anti-Osteoporotic Treatments on Circulating and Bone MicroRNA Patterns in Osteopenic ZDF Rats (2022) (0)
- Effect of nutrient intake on markers of bone turnover in preterm infants. (2001) (0)
- OPC04High circulating serotonin in carcinoid syndrome is not associated with alterations in bone turnover or bone density (2012) (0)
- independently of osteoclastic activation in men A bout of resistance exercise increases urinary calcium (2015) (0)
- Characteristics of patients who suffer major osteoporotic fractures despite adhering to bisphosphonate treatment: A national prescription register study (2012) (0)
- Bone Growth in Childhood and Adolescence: The Interpretation of Dietary Supplementation Trials (1998) (0)
- Definitions and Interpretation of Bone Mineral Density in a Clinical Context (2000) (0)
- Urinary excretion of C-telopeptide isomers in premenopausal and postmenopausal women (2009) (0)
- Albumin-adjusted calcium equation and reference interval for adjusted calcium. Data from the UK Biobank (2020) (0)
- I117 Measurement of bone turnover markers: when is it useful clinically? (2019) (0)
- Increased bone resorption is associated with greater seasonal fluctuation or ‘cycling’ of 25-hydroxyvitamin D (2015) (0)
- The relationship between bone mineral density and bone turnover markers in women at peak bone mass (2011) (0)
- Endocrine oncology and neuroendocrine disorders (2018) (0)
- Increased fat mass may be protective of bone mass in young male cancer survivors (2010) (0)
- Bone peripheral microarchitecture in type 1 diabetes with and without neuropathy; a cross-section study (2020) (0)
- Heritability and familial correlations of the bone synthesis marker, serum N-terminal COL1A1, propeptide (P1NP). (2003) (0)
- Effect of etidronate therapy on bone turnover and bone density in mild paget's disease (1995) (0)
- List of contributors (2021) (0)
- PP-5-4 Does Tamoxifen (Tam) increase bone resorption in premenopausal women? (1996) (0)
- The mechanism for consolidation of bone mass in young men and women: A high resolution quantitative computed tomography study (2011) (0)
- Selenium supplementation to improve bone health in postmenopausal women: the SeMS three-arm RCT (2021) (0)
- Endocrine effects of depot medroxyprogesterone acetate in young women (2007) (0)
- Oestrogen and the skeleton (2004) (0)
- The mechanism for ageing of bone mass in older men and women: A high resolution quantitative computed tomography study (2011) (0)
- MON-532 Urinary Calcium Indices in Primary Hyperparathyroidism (PHPT) and Familial Hypocalciuric Hypercalcaemia (FHH): Is There a Need for Better Discrimination? (2019) (0)
- Comparison of Vertebral Strengths Derived from FE models of the Vertebral Body and the Vertebral Body with Posterior Elements (2014) (0)
- The Effect of Calcium Supplementation on the Circadian Rhythm of Bone Resorption (1995) (0)
- Bone turnover and total body bone mineral in girls during puberty (1992) (0)
- P0885THE RELATIONSHIP BETWEEN BONE REGULATORY MARKERS AND BONE TURNOVER IN RENAL OSTEODYSTROPHY (2020) (0)
- Natural history of maternal urinary beta-C-terminal telopeptide of type I collagen (CTX) in pregnancy, and response to cholecalciferol supplementation: findings from the MAVIDOS trial (2018) (0)
- Optimising the Benefits of Hormone Replacement Therapy for Osteoporosis (1999) (0)
- Hormone resistance syndromes (2018) (0)
- Hormones and fracture risk in postmenopausal women: The OPUS study (2009) (0)
- POORER LIPID PROFILE ARE ASSOCIATED WITH INCREASED BONE RESORPTION AND PARATHYROID HORMONE: PRELIMINARY RESULTS OF THE D-FINES STUDY (2010) (0)
- Trabecular bone structure in advanced chronic kidney disease: Comparison of bone biopsy assessment using microCT and histomorphometry (2021) (0)
- Authors’ response to KD Stathopoulos regarding “Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures” (2021) (0)
- Erratum to: Effects of calcium-fortified ice cream on markers of bone health (2011) (0)
- The impact of endogenous cortisone on bone and fat: demonstration of in vivo 11beta-hydroxysteroid dehydrogenase type 1 activity (2004) (0)
- inhibitor AZD 0424 (2018) (0)
- Type I collagen degradation during tissue repair: Comparison of mechanisms following fracture and myocardial infarction (2012) (0)
- Principles of endocrinology (2018) (0)
- VARIATION WITHIN THE GENE ENCODING SFRP-3 AFFECTS BONE PHENOTYPE BEFORE AND AFTER TOTAL HIP ARTHROPLASTY (2008) (0)
- Evidence of a link between poor bone health, low vitamin D status and CVD risk in caucasian and asian women (2011) (0)
- In Reply to 'Risks of Hip and Nonvertebral Fractures in Patients With CKD'. (2021) (0)
- Postmenopausal osteoporosis: balancing the risks and benefits (2020) (0)
- Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture (2021) (0)
- O13. Rates of bone loss in primary biliary cirrhosis treated with methotrexate (1996) (0)
- Comparison of hand bone density and finger ultrasound after distal forearm fracture (2006) (0)
- Correction to: A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM) (2021) (0)
- Workshop session V. Management of corticosteroid-induced osteoporosis (1996) (0)
- Are non-fracture vertebral deformities more prevalent in patients with osteoporotic vertebral fractures? (2021) (0)
- P26. Urinary galactosyl hydroxylysine as a marker of bone resorption (1994) (0)
- COL1A1 sp1 promoter polymorphism influences serum n-terminal COL1A1 propeptide (P1NP) levels. (2003) (0)
- Once-yearly zoledronic acid increases the proximal femur strength as assessed by finite element analysis of QCT scans (2009) (0)
- P60. Effect of calcium supplementation on the circadian rhythm of bone resorption (1994) (0)
- New and emerging therapies for osteoporosis (2012) (0)
- Comparison of lateral decubitus and supine lateral vertebral fracture assessment (VFA) techniques (2011) (0)
- Hip fracture in older women: Association with the femoral strength as assessed by finite element analysis of DXA scans (2011) (0)
- Greater seasonal cycling of 25-hydroxyvitamin D is 1 associated with increased parathyroid hormone and bone 2 resorption 3 4 (0)
- P40 PREDICTING THE EFFECT OF WEAR RATE REDUCTION ON THE INCIDENCE OF ASEPTIC LOOSENING (2008) (0)
- Denosumab's dynamic CTX profile is maintained over 6 years of treatment: first 3 years of the FREEDOM extension study (2013) (0)
- O3446 THE RELATIONSHIP BETWEEN THREE MEASUREMENTS OF BONE QUALITY AND BONE STRENGTH OF THE TIBIAL PLATEAU (2004) (0)
- Society for Endocrinology Medal Lecture (2004) (0)
- Circulating microRNA analysis in ZDF rats as a model for the identification of biomarkers and disease mechanisms in diabetic osteopathy (2021) (0)
- Population-based geographic variations and determinants of BMD change in elderly men and women across Europe. Results from the Network for Male Osteoporosis (NEMO) study (2005) (0)
- Detection of a genetic predisposition for osteoporosis (1997) (0)
- Bonemineral density andboneturnoverinspinal osteoarthrosis (1995) (0)
- Osteoporosis and metabolic bone disease (2005) (0)
- Effect of Denosumab on Osteolytic Lesion Activity after Total Hip Arthroplasty: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Proof-of-Concept Study (2020) (0)
- Wnt16 Is associated with bone mineral density, osteoporotic fracture and bone strength: a Large-Scale Meta-Analysis of Genomewide Association Studies (2012) (0)
- Quantitating Age‐Related BMD Textural Variation from DXA Region‐Free‐Analysis: A Study of Hip Fracture Prediction in Three Cohorts (2022) (0)
- Preliminary evidence for menopausal but not ethnic or seasonal differences in bone resorption as measured by serum C-telopeptide: Early results of the D-FINES study (2010) (0)
- Effect of light and gamma irradiation on pyridinolines in urine (1995) (0)
- Relationships between baseline dheas in postmenopausal women and bone density, bone loss and incident fracture (2010) (0)
- PRO-INFLAMMATORY CYTOKINE MRNA EXPRESSION IN MACROPHAGES STIMULATED WITH CLEAN AND ENDOTOXIN CONTAMINATED TITANIUM PARTICLES (2006) (0)
- Vitamin D therapy: the effects of race, skin colour and genotype (2016) (0)
- Longterm management of Osteoporosis treatment: Treatment failure, treatment breaks (2016) (0)
- An association between seasonal fluctuation 'cycling' of 25(OH)D and increased bone resorption but not BMD or BMC in UK South Asian and Caucasian women living at 51on (2011) (0)
- Subject Index Vol. 64, Suppl. 2, 2005 (2005) (0)
- National observational study of subtrochanteric, femoral shaft and hip fractures in new alendronate users 1996-2013 (2015) (0)
- A randomized trial (2011) (0)
- Opposing Effects of Childhood Obesity on Radial and Tibial Bone Microstructure (2014) (0)
- Denosumab Significantly Improves Total, Trabecular, and Cortical Estimated Strength at the Hip and Spine Over the Duration of the FREEDOM Trial (2011) (0)
- Urinary excretion of pyridinium cross-links during menopause studied longitudinally (1992) (0)
- Factors influencing levels of bone resorption during denosumab dosing (2013) (0)
- Vertebral Augmentation : A Second ASBMR Task Force Report (2018) (0)
- THE EFFECT OF LOW-DOSE ALUMINUM ON BONE TURNOVER IN PRETERM INFANTS (1998) (0)
- P29. The measurement of pyridinium crosslinks in serum as a biochemical marker of bone turnover in horses (1996) (0)
- Mineral metabolism. (2018) (0)
- P1. Rates of vertebral bone loss measured using two different manufacturers' densitometers (1994) (0)
- Role of cortisol in the pathogenesis of postmenopausal osteoporosis: relationship to bone structure (2014) (0)
- The Use of Artificial Neural Networks to Predict Osteoporosis (1994) (0)
- World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Satellite Sponsored Symposium Abstracts (2021) (0)
- 10. Effect of age on bone collagen turnover in older women (1992) (0)
- PELVIC BONE MINERAL DENSITY CHANGE AFTER TOTAL HIP ARTHROPLASTY USING THE CHARNLEY CUP (2006) (0)
- Skeletal Health in Adulthood (2007) (0)
- British Association for the Study of the Liver Meeting (2000) (0)
- Vitamin D deficiency, poor bone health and the risk of CVD in Caucasian and South Asian women: analysis from the D-FINES study (2011) (0)
- Bone mineral density and micro-architectural changes in advanced chronic kidney disease (2014) (0)
- The response of the immature equine skeleton to physical training. A biochemical study (1995) (0)
- Greater Seasonal Fluctuation or 'Cycling' of 25-Hydroxyvitamin D is Associated with Increased Bone Resorption (2014) (0)
- Serum osteocalcin concentrations in patients with glucocorticoid-induced osteoporosis treated with alendronate or teriparatide (2009) (0)
- Early changes in bone turnover markers are associated with increases in BMD during treatment with blosozumab in postmenopausal women with low BMD (2015) (0)
- Evaluation of morphometric x-ray absorptiometry (2006) (0)
- Acute careInvestigating suspected osteoporosis (2007) (0)
- The effect of bisphosphonate treatment on sclerostin levels in postmenopausal osteoporosis: the TRIO study (2014) (0)
- The response of fibroblast growth factor-23 to teriparatide in postmenopausal osteoporosis (2016) (0)
- Influence of skin colour, ethnicity, and genotype on the response to vitamin D treatment (2015) (0)
- Bone mineral density as a surrogate biomarker for fracture risk reduction - Authors' reply. (2020) (0)
- O1. Interleukin 1 receptor antagonist and postmenopausal bone loss (1994) (0)
- POLYMORPHISM IN THE INTERLEUKIN-6 GENE PROMOTER AND RISK OF ASEPTIC LOOSENING (2008) (0)
- Promoter Region Polymorphism in the TNF Gene and Risk of Osteolysis after Total Hip Arthroplasty (2002) (0)
- EFFECT OF AROMATASE INHIBITION ON BONE DENSITY AND BONE TURNOVER IN HEALTHY POSTMENOPAUSAL WOMEN: RESULTS OF THE INTERNATIONAL BREAST CANCER INTERVENTION STUDY II (IBIS-II) (2014) (0)
- Increased trabecular number and density in Lrp5-HBM patients – evaluation by HR-pQCT (2010) (0)
- P56. Bone mineral density in women with previous ankle fracture (1996) (0)
- The 7Q31 locus, containing WNT16, is associated with bone mineral density, osteoporotic fracture and bone strength (2012) (0)
- Osteoporosis (2021) (0)
- GDF15, a potential marker of cell senescence, and increased risk of hip fracture (2022) (0)
- Update on the Endocrine Society osteoporosis in men guideline (2012) (0)
- Bone mineral density and vascular calcification in obesity (2016) (0)
- JCEM ARCHIVEOsteoporosis in Men: An Endocrine Society Clinical Practice Guideline (2013) (0)
- POLYMORPHISM AT +3954 IN THE IL-1B GENE AND RISK OF ASEPTIC LOOSENING AFTER TOTAL HIP ARTHROPLASTY (2004) (0)
- "Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: a population-based cohort study". (2022) (0)
- Female hormone metabolism (2018) (0)
- Relationship between Selenium Status and Baseline Characteristics in Older Women with low Bone Mineral Density (2020) (0)
- Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period (2019) (0)
- A Bone to Pick with Local Glucocorticoid Activation (2003) (0)
- Bone turnover markers: an appreciation of the contribution of Dr. P.D. Delmas. (2008) (0)
- Bone turnover markers: response to comments by Seeman and Nguyen (2015) (0)
- Determination of bone resorption (2020) (0)
- Determinants of the Circadian Rhythm of Bone Collagen Degradation in Human Subjects (1994) (0)
- Bone densitometry. Can predict those at high risk of fractures. (1994) (0)
- BONE REMODELLING UNITS, STRESS SHIELDING, AND PAMIDRONATE THERAPY AFTER THA (2002) (0)
- Laboratory Assessment of Skeletal Status (2003) (0)
- A Contextual Feature-Based Recognition Approach to Quantify Trabecular Microstructure Using 1.5T Axial-MRI: An Innovative Methodology (2015) (0)
- Bone (2018) (0)
- Fat, adipokines, bone structure and bone regulatory factors associations in obesity (2022) (0)
- Urinary Cortisol Excretion in Patients with Alcoholic Myopathy (1985) (0)
- Endocrine investigation, nursing, and dietetics (2018) (0)
- Male hormone metabolism (2018) (0)
- Evidence of an association between seasonal cycling of 25(OH)D and markers of bone health in UK South Asian but not Caucasian women living at 51oN (2010) (0)
- Discovery of microRNA biomarkers in circulation and bone tissue from a type-2 diabetes mellitus rat model under different anti-osteoporotic treatments (2022) (0)
- P55. Bone turnover in men after cardiac transplantation (1996) (0)
- Review for "Nitrogen‐Containing Bisphosphonates Are Associated With Reduced Risk of Pneumonia in Patients With Hip Fracture" (2019) (0)
- Improving the Hip Fracture Risk Prediction with a Statistical Shape-and-Intensity Model of the Proximal Femur (2022) (0)
- The Effect of BsmI and FokI Genotypes on Bone Density and Bone Turnover Response to Raloxifene Therapy (2004) (0)
- PRIMENENIE ZOLEDRONOVOY KISLOTY 5 MG (PREPARAT «AKLASTA») ODIN RAZ V GOD dlya lecheniyazhenshchin s postmenopauzal'nym osteoporozom (issledovanie horizon-pft) (2008) (0)
This paper list is powered by the following services:
Other Resources About Richard Eastell
What Schools Are Affiliated With Richard Eastell?
Richard Eastell is affiliated with the following schools:
